Is CHGCY or EQR a better dividend investment in 2026?

CHGCY currently yields 2.99% with a 5% 5-year dividend growth rate. EQR yields 5.87% with 5% growth. The better choice depends on your goal: EQR offers higher current income.

What is the dividend yield difference between CHGCY and EQR?

CHGCY has a forward dividend yield of 2.99% ($0.82/share annually). EQR yields 5.87% ($3.47/share annually). The yield gap is 2.88 percentage points.

Home › Compare › CHGCY vs EQR

CHGCY vs EQR: Dividend Comparison 2026

CHGCY yields 2.99% · EQR yields 5.87%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 CHGCY wins by $405.78M in total portfolio value· pulled ahead in Year 2

INVESTMENT

TIME HORIZON10 years

CHGCY

● Live price

2.99%

Share price

$27.52

Annual div

$0.82

5Y div CAGR

100%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$405.82M

Annual income

$381,294,826.82

Full CHGCY calculator →

EQR

● Live price

5.87%

Share price

$59.15

Annual div

$3.47

5Y div CAGR

15.8%

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$47.8K

Annual income

$5,475.61

Full EQR calculator →

Portfolio growth — CHGCY vs EQR

📍 CHGCY pulled ahead of the other in Year 2

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	CHGCY	EQR
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, CHGCY + EQR cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

CHGCY pays

EQR pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

CHGCY

Annual income on $10K today (after 15% tax)

$253.82/yr

After 10yr DRIP, annual income (after tax)

$324,100,602.80/yr

EQR

Annual income on $10K today (after 15% tax)

$499.01/yr

After 10yr DRIP, annual income (after tax)

$4,654.27/yr

At 15% tax rate, CHGCY beats the other by $324,095,948.53/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of CHGCY + EQR for your $10,000?

CHGCY: 50%EQR: 50%

100% EQR50/50100% CHGCY

Portfolio after 10yr

$202.94M

Annual income

$190,650,151.21/yr

Blended yield

93.95%

📊

Analyst Conviction Gap

Where Wall Street is most bullish on EQR right now

CHGCY

No analyst data

Altman Z

22.5

Piotroski

6/9

EQR

Analyst Ratings

Buy

Hold

Sell

Consensus: Hold

Price Target

$70.35

+18.9% upside vs current

Range: $63.00 — $78.50

Altman Z

1.8

Piotroski

7/9

Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

CHGCY buys

EQR buys

Politician	Chamber	Ticker	Type	Amount	Date
Josh Gottheimer	🏢 House	$CHGCY	▼ Sell	$1,001 - $15,000	2025-04-09
Josh Gottheimer	🏢 House	$CHGCY	▼ Sell	$1,001 - $15,000	2024-06-21
Josh Gottheimer	🏢 House	$CHGCY	▼ Sell	$1,001 - $15,000	2024-04-04
Josh Gottheimer	🏢 House	$CHGCY	▲ Buy	$1,001 - $15,000	2023-08-18
Daniel Goldman	🏢 House	$CHGCY	▼ Sell	$1,001 - $15,000	2023-07-10
Daniel Goldman	🏢 House	$CHGCY	▼ Sell	$15,001 - $50,000	2023-03-31
Daniel Goldman	🏢 House	$CHGCY	▲ Buy	$1,001 - $15,000	2023-02-27
Peter Meijer	🏢 House	$CHGCY	▼ Sell	$15,001 - $50,000	2021-02-17
Greg Gianforte	🏢 House	$CHGCY	▼ Sell	$50,001 - $100,000	2020-04-14
Josh Gottheimer	🏢 House	$CHGCY	▼ Sell	$1,001 - $15,000	2020-04-13

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricCHGCYEQR

Forward yield	2.99%	5.87% ✓
Annual dividend / share	$0.82	$3.47 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	100% ✓	15.8%
Portfolio after 10y	$405.82M ✓	$47.8K
Annual income after 10y	$381,294,826.82 ✓	$5,475.61
Total dividends collected	$404.01M ✓	$23.0K
Payment frequency	quarterly	quarterly
Sector	Stock	REIT

Year-by-year: CHGCY vs EQR ($10,000, DRIP)

Year	CHGCY Portfolio	CHGCY Income/yr	EQR Portfolio	EQR Income/yr	Gap
1	$11,297	$597.22	$11,380	$679.82	$83.00 → EQR
2← crossover	$13,349	$1,261.10	$13,014	$837.25	+$335.00 → CHGCY
3	$17,069	$2,785.33	$14,961	$1,036.20	+$2.1K → CHGCY
4	$24,921	$6,656.96	$17,297	$1,289.22	+$7.6K → CHGCY
5	$44,832	$18,166.72	$20,121	$1,613.15	+$24.7K → CHGCY
6	$109,057	$61,087.10	$23,561	$2,030.84	+$85.5K → CHGCY
7	$394,447	$277,755.94	$27,783	$2,573.54	+$366.7K → CHGCY
8	$2,299,836	$1,877,777.60	$33,013	$3,284.39	+$2.27M → CHGCY
9	$22,925,198	$20,464,373.86	$39,547	$4,223.51	+$22.89M → CHGCY
10	$405,824,789	$381,294,826.82	$47,791	$5,475.61	+$405.78M → CHGCY

CHGCY vs EQR: Complete Analysis 2026

CHGCY — Stock

Chugai Pharmaceutical Co., Ltd., together with its subsidiaries, engages in the research, development, manufacturing, sale, importation, and exportation of pharmaceuticals in Japan and internationally. The company's products for oncology primarily include Avastin, Tecentriq, Perjeta, Alecensa, Herceptin, Kadcyla, Rituxan, Gazyva, and Xeloda; osteoporosis, including Actemra, Edirol, and Bonviva; renal diseases consist of Mircera and Oxarol; and neurology/other diseases comprise Hemlibra, CellCept, and Enspryng. It has various development product candidates in the areas of oncology, bone and joint diseases, autoimmune diseases, renal diseases, neurology, and other diseases. Chugai Pharmaceutical Co., Ltd. has strategic alliances with Roche Group; and collaboration and joint research with academia. The company was founded in 1925 and is headquartered in Tokyo, Japan. Chugai Pharmaceutical Co., Ltd. is a subsidiary of Roche Holding Ltd.

Full CHGCY Calculator →

EQR — REIT

Equity Residential is committed to creating communities where people thrive. The Company, a member of the S&P 500, is focused on the acquisition, development and management of residential properties located in and around dynamic cities that attract high quality long-term renters. Equity Residential owns or has investments in 305 properties consisting of 78,568 apartment units, located in Boston, New York, Washington, D.C., Seattle, San Francisco, Southern California and Denver.

Full EQR Calculator →

📬

Get this CHGCY vs EQR comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

CHGCY vs SCHD CHGCY vs JEPI CHGCY vs O CHGCY vs KO CHGCY vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.